June 17, 2018 9:00 PM ET


Company Overview of Zocere, Inc.

Company Overview

Zocere, Inc., a pharmaceutical company, develops a post-stroke injectable neuro-protectant drug to combat stroke and other neurological trauma. Its drugs are designed to protect patients from brain injury by arresting the progression of neurological damage caused by reduced blood flow. Zocere, Inc. was formerly known as Tyrosine Pharma Inc. and changed its name to Zocere, Inc. in January 2014. The company was founded in 2012 and is based in Albuquerque, New Mexico.

1155 University Boulevard NE

Albuquerque, NM 87106

United States

Founded in 2012



Key Executives for Zocere, Inc.

Chief Executive Officer and President
Chief Technology Officer
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
Praetego, Inc. United States
1st Order Pharmaceuticals, Inc. United States
21st Century Animal Health United States
3 Buds' Organics LLC United States
60° Pharmaceuticals, LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Zocere, Inc., please visit www.tyrosinepharma.com. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.